Inovalon Holdings, Inc., a technology company, provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models in the healthcare industry.
The last earnings update was 52 days ago.
Discounted Cash Flow Calculation for DB:IOV using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for
is arrived at by discounting future cash flows to their present value using the 2 stage method. We use
analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.
DB:IOV DCF 1st Stage: Next 5 year cash flow forecast
The current share price of
is above its future cash flow value.
Often investors are willing to pay a
for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Inovalon Holdings's earnings available for a low price, and how does
this compare to other companies in the same industry?
Inovalon Holdings's earnings are expected to grow significantly at over 20% yearly.
Inovalon Holdings's revenue is expected to grow by 11.8% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Inovalon Holdings's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
Inovalon Holdings's finances.
The net worth of a company is the difference between its assets and liabilities.
Inovalon Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Inovalon Holdings's long term commitments exceed its cash and other short term assets.
This treemap shows a more detailed breakdown of
Inovalon Holdings's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
Low level of unsold assets.
Debt is not covered by short term assets, assets are 0.2x debt.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Dr. Keith R. Dunleavy, M.D., has been the Chairman of Inovalon Holdings, Inc. since 2006 and its Chief Executive Officer since 1998. Dr. Dunleavy is responsible for the overall execution of Inovalon Holdings, Inc.’s business plan, expansion of strategic relationships and the identification and realization of Company product strategy and vision. He served as the President of Inovalon, Inc. until May 19, 2014. During his tenure at Inovalon, He has worked extensively with a wide array and number of healthcare organizations, regulatory and oversight bodies and technology companies examining the growing role of data within healthcare and its ability to drive meaningful insight and improvement for its constituents. Driven by a vision of data's ability to drive insight and improvement in healthcare, He led Inovalon from its origins to its current industry-leading position leveraging advanced, cloud-based analytical and data-driven intervention platforms. Prior to organizing predecessor companies of Inovalon, Dr. Dunleavy worked in areas of management consulting designed to leverage the benefits of multidisciplinary personnel teams with prowess within the basic sciences, software technology, business strategy, finance and operational scaling. In this role, he has served in a wide range of design, strategy and management positions for an array of basic science research, corporate development initiatives and private equity projects. He has been a Director of Inovalon Holdings, Inc. since 2006. He serves as a Director of Board of Overseers at Dartmouth Medical School. He has authored or co-authored a number of scientific journal articles, abstracts and proprietary research papers and has presented his work and materials at multiple national and international conferences. He received a Bachelor’s degree in Biology modified with Engineering with High Honors from Dartmouth College where his thesis work focused on applications of computer-simulated artificial human cerebellar functional units. Dr. Dunleavy earned his doctorate in medicine from Harvard Medical School, completed his medical residency at The Johns Hopkins Hospital in Baltimore, Maryland, practiced and was Board Certified in Internal Medicine.
Keith's compensation has been consistent with company performance over the past year.
Keith's remuneration is lower than average for companies of similar size in Germany.
Management Team Tenure
Average tenure and age of the
management team in years:
The tenure for the Inovalon Holdings management team is about average.
Chairman & CEO
Chief Product Officer
Interim Chief Financial Officer
Chief Operating Officer
Senior Vice President of Corporate Marketing & Communications
Senior Vice President of Innovation & Data Strategies
Senior Vice President of Business Solutions & Sales
Senior Vice President of Quality Products & Solutions
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The tenure for the Inovalon Holdings board of directors is about average.
Inovalon Holdings, Inc., a technology company, provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models in the healthcare industry. The company’s platform enables the assessment and enhancement of clinical and quality outcomes and financial performance. It serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. The company provides technology that supports approximately 500 healthcare organizations. Its platforms are informed by data pertaining to approximately 932,000 physicians; 455,000 clinical facilities; and approximately 240 million individuals and 37 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.